본문 바로가기
KERD
논문KCI 등재

Euryale ferox Salisbury의 항산화효과 및 LDL 산화 억제효과 탐색

Screening of Antioxidative Effect and Suppressive Effect of LDL Oxidation of Euryale ferox Salisbury

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류한의학

초록

Topical natural antioxidants are a useful strategy for the prevention of oxidative stress mediated cardiovascular disease including atherosclerosis. From the viewpoint of this underlying principle, the screening of natural plant extracts with scavenging activity for pro-oxidant reactive species is a primary requirement for the development of new topical antioxidant formulations. Euryale ferox Salisbury (EF) is botanical name and it’s pharmaceutical name is EURYALES SEMEN (ES) . The stems and branchs of EF have been used as a traditional herbal medicine for the treatment of dysentery, diarrhea, leucorrhoea, incontinence and paralysis of joint. In this study, the antioxidant activity of extract from EF was studied in vitro methods by measuring the antioxidant activity and free radical scavenging activity by TEAC and DPPH, measuring the scavenging effects on reactive oxygen species (ROS) [superoxide anion, hydroxyl radical] and on reactive nitrogen species (RNS) [nitric oxide and peroxynitrite] as well as measuring the inhibitory effect on Cu2+-induced human LDL oxidation. The EF extracts were found to have a potent scavenging activity, as well as an inhibitory effect on LDL oxidation. In conclusion, the EF extracts have antioxidative effects in vitro system, which can be used for developing pharmaceutical drug against oxidative stress and chronic degenerative disease such as atherosclerosis.

Abstract

Topical natural antioxidants are a useful strategy for the prevention of oxidative stress mediated cardiovascular disease including atherosclerosis. From the viewpoint of this underlying principle, the screening of natural plant extracts with scavenging activity for pro-oxidant reactive species is a primary requirement for the development of new topical antioxidant formulations. Euryale ferox Salisbury (EF) is botanical name and it’s pharmaceutical name is EURYALES SEMEN (ES) . The stems and branchs of EF have been used as a traditional herbal medicine for the treatment of dysentery, diarrhea, leucorrhoea, incontinence and paralysis of joint. In this study, the antioxidant activity of extract from EF was studied in vitro methods by measuring the antioxidant activity and free radical scavenging activity by TEAC and DPPH, measuring the scavenging effects on reactive oxygen species (ROS) [superoxide anion, hydroxyl radical] and on reactive nitrogen species (RNS) [nitric oxide and peroxynitrite] as well as measuring the inhibitory effect on Cu2+-induced human LDL oxidation. The EF extracts were found to have a potent scavenging activity, as well as an inhibitory effect on LDL oxidation. In conclusion, the EF extracts have antioxidative effects in vitro system, which can be used for developing pharmaceutical drug against oxidative stress and chronic degenerative disease such as atherosclerosis.

참고문헌 (40)

  1. 全國韓醫科大學 共同敎材編纂委員會, "本草學", pp.233~234 (1991), 永林社
  2. 鄭普變 辛民敎, "鄕藥(生藥)大辭典", pp.938~940 (1990), 圖書出版 永林社
  3. Row, L.C, "Cerebrosides and tocopherol trimers from the seeds of Euryale ferox", J Nat Prod, 70, pp.1214~1217 (2007)
  4. Zhao, H.R, "Glucosylsterols in extracts of Euryale ferox identified by high resolution NMR and mass spectrometry", J Lipid Res, 30, pp.1633~1637 (1989)
  5. SiEunLee, "Antioxidant activity of extracts from Euryale ferox seed", Experimental and Molecular Medicine, 34(2), pp.2~106 (2002), 생화학분자생물학회
  6. Puri, A, "Immunostimulant activity of dry fruits and plant materials used in indian traditional medical system for mothers after child birth and invalids", J Ethnopharmacol, 71, pp.89~92 (2000)
  7. Das, S., "The effect of Euryale ferox (Makhana), an herb of aquatic origin, on myocardial ischemic reperfusion injury", Mol Cell Biochem, 289(1), pp.55~63 (2006)
  8. Aruoma, O.I, "Free radicals, oxidative stress and antioxidants in human health and disease", J Am Oil Chem Soc, 75, pp.199~212 (1998)
  9. Finkel, T., "oxidative stress and the biology of ageing", Nature, 408(6809), pp.239~247 (2000)
  10. Frank, M.S, "Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoprotein and cardiovascular disease", Am J Med, 113, pp.13~24 (2002)
  11. Libby, P, "Inflammation in atherosclerosis", Nature, 420, pp.868~874 (2002)
  12. Berliner, J.A., "The role of oxidized lipoproteins in atherogenesis", Free Radic Biol Med, 20, pp.707~727 (1996)
  13. Meagher, E, "Antioxidant theraphy and atherosclerosis: animal and human studies", Trends Cardiovasc Med, 11, pp.162~165 (2001)
  14. Yokoyama, M, "Oxidant stress and atherosclerosis", Cur Opin Pharmacol, 4, pp.110~115 (2004)
  15. 김현정, "부위별 새송이버섯 추출물의 항산화 및 항균효과", 한국식품과학회지, 38(6), pp.799~804 (2006), 한국식품과학회
  16. Ali, K.A, "Tea and herbal infusions: Their antioxidant activity and phenolic propolis", Food Chem, 89, pp.27~36 (2005)
  17. Barene, A.L, "Toxicological and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene", J Am Oil Chem Soc, 52, pp.59~63 (1975)
  18. Farbstein, D, "Antioxidant vitamins and their use in preventing cardiovascular disease", Molecules, 15(11), pp.8098~8110 (2010)
  19. Massaro, M, "Nutraceuticals and prevention of atherosclerosis: focus on omega-3 polyunsaturated fatty acids and Mediterranean diet polyphenols", Cardiovasc Ther, 28(4), pp.e13~e19 (2010)
  20. de Pascual-Teresa, S, "Flavanols and anthocyanins in cardiovascular health: a review of current evidence", Int J Mol Sci, 11(4), pp.1679~1703 (2010)
  21. Kujala, T.S, "Phenolic and betacyanins in red beetroot (Beta vulgaris) root: distribution and effects of cold storage on the content of total phenolics and three individual compounds", J Agri Food Chem, 48, pp.5338~5342 (2000)
  22. Roberta, R.E, "Antioxidant activity applying an improved ABTS radical cation decolorization assay", Free Radic Biol Med, 26, pp.1231~1237 (1999)
  23. Miller, N.J, "A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates", Clin Sci, 84, pp.407~412 (1993)
  24. Blois, M.S, "Antioxidant determination by the use of stable free radical", Nature, 26, pp.1199~1200 (1958)
  25. Gotoh, N, "Rates of interactions of superoxide with vitamin E, vitamin C and related compounds as measured by chemiluminescence", Biochem Biophys Acta, 1115, pp.201~207 (1992)
  26. Halliwell, B, "Role of free radicals and catalytic metalions in human disease: an overview", Method Enzymol, 186, pp.1~85 (1990)
  27. Nagata, N., "Inhibitory effects of catecholamines and anti-oxidants on the fluorescence reactionof 4,5-diaminofluorescein, DAF-2, a novel indicator of nitric oxide", J Biochem, 125, pp.658~661 (1999)
  28. Crow, J.P, "Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species", Nitric Oxide, 1, pp.145~157 (1997)
  29. Yagi, K.A, "Simple fluometric assay for lipoperoxide in blood plasma", Biochem Med, 15, pp.212~216 (1976)
  30. Rice-Evans, C, "Structure-antioxidant activity relationships of flavonoids and phenolic acids", Free Radic Biol Med, 20, pp.933~956 (1996)
  31. Kaur, C, "Anti-oxidant activity and total phenolic content of some Asian vegetables", Int J Food Sci Technol, 37, pp.153~161 (2002)
  32. Maisuthisakul, P, "Assessment of phenolic content and free radical-scavenging capacity of some Thai indigenous plants", Food Chem, 100(4), pp.1409~1418 (2007)
  33. Awika, J.M., "Screening methods to measure antioxidant activity of sorghum (Sorghum bicolor) and sorghum products", J Agric Food Chem, 51, pp.6657~6662 (2003)
  34. Molyneux, P, "The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity", J Sci Tech, 26, pp.211~219 (2004)
  35. Halliwell, B, "Oxygen toxicology, oxygen radicals, transition metals and disease", Biochem J, 219, pp.1~4 (1984)
  36. Patel, R.P., "Biological aspects of reactive nitrogen species", Biochim Biophys Acta, 1411, pp.385~400 (1999)
  37. Salvemini, D, "Nitric oxide activates cyclooxygenase enzymes", Proc Natl Acad Sci, 90, pp.7240~7244 (1993)
  38. Channon, K.M., "Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy", Arterioscler Thromb Vasc Biol, 20, pp.1873~1881 (2000)
  39. Witzum, J.L, "The role of monocytes and oxidized LDL in atherosclerosis, In Atherosclerosis Reviews", Ravan Press, 21, pp.59~69 (1990)
  40. Raya, A.A., "Inflammation: A pivotal link between autoimmune diseases and atherosclerosis", Autoimmun Rev, 5, pp.331~337 (2006)

관련 논문AI추천

이 간행물의 다른 논문 (13건)